| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to psychiatry, and can be used for correction of drug-induced parkinsonism presented by muscular rigidity, tremor, torsion dystonia and/or acathisia. That is ensured by centrally acting muscle relaxant tizanidine. The preparation is administered 1-3 times in daily dose 2-12 mg. ^ EFFECT: without reducing dosage of an antipsychotic agent, the invention allows for effective correction of drug-induced parkinsonism manifestations without risk of psychosis exacerbation, development of drug dependence and cognitive toxicity. ^ 1 ex, 1 tbl |
